National survey of non-small cell lung cancer in the United States: Epidemiology, pathology and patterns of care

Lung Cancer

Volumn 57, Issue 3, 2007, Pages 253-260

  Little, Alex G ^a   Gay, E Greer ^b   Gaspar, Laurie E ^c   Stewart, Andrew K ^b  

^a WRIGHT STATE UNIVERSITY   (United States)

^b AMERICAN COLLEGE OF SURGEONS   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Diagnosis; Lung cancer; Staging; Treatment

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; HEALTH CARE; HISTOPATHOLOGY; HUMAN; INFORMATION PROCESSING; LIFESTYLE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; MULTIMODALITY CANCER THERAPY; PATIENT CARE; PATIENT INFORMATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RACE DIFFERENCE; RADIODIAGNOSIS; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; UNITED STATES;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; UNITED STATES;

EID: 34548030471     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.03.012     Document Type: Article

References (32)

1. American Cancer Society. Cancer facts and figures 2006 (2006), American Cancer Society, Atlanta, GA pp. 5-6
2. Humphrey E.W., Smart C.R., Winchester D.P., et al. National survey of the pattern of care for carcinoma of the lung. J Thorac Cardiovasc Surg 100 (1990) 837-843
3. Fry W.A., Phillips J.L., and Menck H.R. Ten-year survey of lung cancer treatment and survival in hospitals in the United States. Cancer 86 9 (1999) 1867-1876
4. Commission on, Cancer, Standards of the Commission on Cancer. Registry operations and data standards vols. I and II (1998), American College of Surgeons, Chicago, IL
5. Standards for cancer registries. In: Hultstrom D. (Ed). Version 10. Chap. IX required status table vol. II (2002), Springfield, IL NAACCR 107-118
6. Shaffer J.P. Multiple hypothesis testing. Ann Rev Psych 46 (1995) 561-584
7. Hoover R. Epidemiology: tobacco and geographic pathology. In: Harris C.C. (Ed). Pathogenesis and therapy of lung cancer (1978), Marcel Dekker, New York
8. Giovino G.A. Epidemiology of tobacco use in the United States. Oncogene 21 48 (2002) 7326-7340
9. Yancik R., Havlik R.J., Wesley M.N., et al. Cancer and comorbidity in older patients: a descriptive profile. Ann Epidemiol 6 (1996) 399-412
10. Stukenborg G.J., Kilbridge K.L., Wagner D.P., et al. Present-at-admission diagnoses improve mortality risk adjustment and allow more accurate assessment of the relationship between volume of lung cancer operations and mortality risk. Surgery 138 3 (2005) 498-507
11. Centers for Disease Control, Prevention. Cigarette smoking among adults vol. 53 (2004), MMWR pp. 427-31
12. US Census Bureau. US Bureau of the Census - 2000. Available from URL: http://censtats.census.gov/data/US/01000.pdf [accessed August 9, 2006].
13. US Census Bureau. Health Status, Health Insurance, and Health Utilization 2001. Available from URL: http://www.census.gov/prod/2006pubs/p70-106.pdf, p. 9 [accessed August 9, 2006].
14. Thun M.J., Lally C.A., Flannery J.T., et al. Cigarette smoking and changes in the histopathology of lung cancer. JNCI 89 21 (1997) 1580-1586
15. Wynder E.L., and Muscat J.E. The changing epidemiology of smoking and lung cancer histology. Environ Health Perspect 103 Suppl. 8 (1995) 142-148
16. Alberg A.J., Brock M.V., and Samet J.M. Epidemiology of lung cancer: looking to the future. J Clin Oncol. 23 14 (2005) 3175-3185
17. Schenk D.A., Bryan C.L., Bower J.H., et al. Transbronchial needle aspiration in the diagnosis of bronchogenic carcinoma. Chest 92 1 (1987) 83-85
18. Wescott J.L. Direct percutaneous needle aspiration of localized pulmonary lesions: results in 422 patients. Radiology 137 (1980) 31-36
19. Verboom P., van Tinteren H., Hoekstra O.S., et al. Cost-effectiveness of FDG-PET staging NSCLC: the PLUS study. Eur J Nucl Med Mol Imaging 30 11 (2003) 1444-1449
20. Nutt P. The history of positron emission tomography. Mol Imaging Biol 4 (2002) 11-26
21. Fontana R.S., Sanderson D.R., Woolner L.B., et al. Lung cancer screening: the Mayo Program. J Occup Med 28 8 (1986) 746-750
22. Henschke C.I., Shaham D., Yankelevitz D.F., and Altorki N.K. CT screening for lung cancer: past and ongoing studies. Semin Thorac Cardiovasc Surg 17 2 (2005) 99-106
23. Haiman C.A., Stram D.O., Wilkens L.R., et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med 354 4 (2006) 333-342
24. Giovino G.A., Sidney S., Gfoerer J.C., et al. Epidemiology of menthol cigarette use. Nicotine Tob Res 6 Suppl. 1 (2004) S67-S81
25. Brooks D.R., Palmer J.R., Strom B.L., et al. Menthol cigarettes and risk of lung cancer. Am J Epidemiol 158 7 (2003) 609-616
26. Laskin J.J., and Sandler A.B. State of the art in therapy for non-small cell lung cancer. Cancer Invest 23 5 (2005) 427-442
27. Langer C. Combined modality therapy: new insights, old roadblocks. Proceedings of the 9th World Conference on Lung Cancer in Tokyo. Japan (2000)
28. Iezonni L.I. Range of risk factors. Risk adjustment for measuring healthcare outcomes. 3rd ed. vol. 43 (2003), Health Administration Press, Chicago, IL p. 49
29. Prout Jr. G.R., Wesley M.N., Yancik R., et al. Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer 104 8 (2005) 1638-1647
30. Iezzoni L.I. Risk and outcomes. Risk adjustment for measuring healthcare outcomes. 2nd ed. (1997), Health Administration Press, Chicago, IL
31. Weitz J., Koch M., Friess H., and Buchler M.W. Impact of volume and specialization for cancer surgery. Dig Surg 21 4 (2004) 253-261
32. Halm E.A., Lee C., and Chassin M.R. Is volume related to outcome in healthcare? A systematic review and methodologic critique of the literature. Ann Int Med 137 6 (2002) 511-520